These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21152247)

  • 1. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.
    Yacoubian TA; Slone SR; Harrington AJ; Hamamichi S; Schieltz JM; Caldwell KA; Caldwell GA; Standaert DG
    Cell Death Dis; 2010; 1(1):e2. PubMed ID: 21152247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.
    Slone SR; Lavalley N; McFerrin M; Wang B; Yacoubian TA
    Neurobiol Dis; 2015 Jul; 79():1-13. PubMed ID: 25862939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax.
    Slone SR; Lesort M; Yacoubian TA
    PLoS One; 2011; 6(7):e21720. PubMed ID: 21799745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.
    Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA
    J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 Proteins in the regulation of rotenone-induced neurotoxicity might be via its isoform 14-3-3epsilon's involvement in autophagy.
    Sai Y; Peng K; Ye F; Zhao X; Zhao Y; Zou Z; Cao J; Dong Z
    Cell Mol Neurobiol; 2013 Nov; 33(8):1109-21. PubMed ID: 24002177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.
    Fountaine TM; Wade-Martins R
    J Neurosci Res; 2007 Feb; 85(2):351-63. PubMed ID: 17131421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.
    Lavalley NJ; Slone SR; Ding H; West AB; Yacoubian TA
    Hum Mol Genet; 2016 Jan; 25(1):109-22. PubMed ID: 26546614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.
    Ruan Q; Harrington AJ; Caldwell KA; Caldwell GA; Standaert DG
    Neurobiol Dis; 2010 Feb; 37(2):330-8. PubMed ID: 19850127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein overexpression represses 14-3-3θ transcription.
    Ding H; Fineberg NS; Gray M; Yacoubian TA
    J Mol Neurosci; 2013 Nov; 51(3):1000-9. PubMed ID: 23912650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.
    Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer JA; Tardiff DF; Strathearn KE; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell KA; Bell GW; Fraenkel E; Cooper AA; Caldwell GA; McCaffery JM; Rochet JC; Lindquist S
    Dis Model Mech; 2010; 3(3-4):194-208. PubMed ID: 20038714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic.
    Hassanzadeh K; Morrone C; Akhtari K; Gerhardt E; Zaccagnini L; Outeiro TF; Feligioni M
    Mech Ageing Dev; 2023 Jan; 209():111759. PubMed ID: 36464085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP(+) Toxicity-Induced Parkinson's Disease Models.
    Lehtonen Š; Jaronen M; Vehviläinen P; Lakso M; Rudgalvyte M; Keksa-Goldsteine V; Wong G; Courtney MJ; Koistinaho J; Goldsteins G
    Antioxid Redox Signal; 2016 Sep; 25(8):485-97. PubMed ID: 27139804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a natural quinoline alkaloid isolated from the deep-sea-derived fungus and its potential as a therapeutic for Parkinson's disease.
    Lee TY; Yang W; Cha DS; Han YT
    J Asian Nat Prod Res; 2023 May; 25(5):446-455. PubMed ID: 35980025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
    Chang CH; Wei CC; Ho CT; Liao VH
    Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
    Callizot N; Combes M; Henriques A; Poindron P
    PLoS One; 2019; 14(4):e0215277. PubMed ID: 31022188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.